Ran Increases Sensitivity of Ovarian Cancer Cells to Oncolytic Virus
Author Information
Author(s): Geoffroy Karen, Viens Mélissa, Kalin Emma Mary, Boudhraa Zied, Roy Dominic Guy, Wu Jian Hui, Provencher Diane, Mes-Masson Anne-Marie, Bourgeois-Daigneault Marie-Claude
Primary Institution: Institut du cancer de Montréal
Hypothesis
Can the small GTPase Ran enhance the effectiveness of oncolytic vesicular stomatitis virus (oVSV) in treating ovarian cancer?
Conclusion
The study suggests that increased Ran expression enhances the sensitivity of ovarian cancer cells to oncolytic vesicular stomatitis virus, indicating potential for improved treatment strategies.
Supporting Evidence
- Most human ovarian cancer cell lines were sensitive to oVSV infection.
- Ran expression was linked to intrinsic sensitivity to oVSV.
- Ran inhibition decreased viral replication and cancer cell killing.
- High Ran expression correlated with better oVSV replication.
- Ran could be used as a biomarker to select ovarian cancer patients for OV therapy.
Takeaway
This study found that a protein called Ran helps a virus that can kill cancer cells work better, which could help treat ovarian cancer.
Methodology
The study evaluated the sensitivity of patient-derived ovarian cancer cell lines to oVSV using overexpression systems, siRNAs, and drug inhibition.
Limitations
All experiments were conducted in EOC cell lines, and the findings may not translate to other cancer types or clinical samples.
Participant Demographics
The study used patient-derived ovarian cancer cell lines of various subtypes.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website